Sydney Vital member, medical oncology fellow at Melanoma Institute Australia (MIA), Dr Carina Owen was awarded a Sydney Vital travel grant to attend the American Society of Clinical Oncology (ASCO) 2019 Annual Meeting in Chicago, US, last month.
Dr Owen presented her research project ” A Multicentre Analysis of Melanoma Recurrence Following Adjuvant Anti-PD1 Therapy” in the Melanoma oral abstract session. Dr Owen’s and her team’s research outcomes suggest that when it comes to optimal management of patients who had a distant recurrence after receiving adjuvant anti–PD-1 monoclonal antibodies for high-risk resected melanoma, some patients may not respond to subsequent anti–PD-1 treatment and should thus change to other types of medications. The presentation was well-received and has won considerable attention and media coverage during the ASCO annual meeting.
“As a junior clinician-researcher, this experience has allowed me to hone my presentation skills to a new level and these skills will be invaluable throughout my career. ” Dr Owen comments.
Throughout the conference, Dr Owen attended many melanoma-and-immunotherapy-themed sessions and learned about current trends in translational and clinical research in these fields. This has also allowed her to network with other researchers and to develop new ideas and potential collaborations for future research.
Sydney Vital would like to congratulate Dr Owen for presenting at the ASCO annual meeting and encourage her to continue her outstanding research.
Click here to read more about Dr Carina Owen’s research project.
Keep up-to-date with our scholarships, funding and awards and check out our grant schemes here.